|
Friday, November 20, 2015
Print Current Session:
 |
|
|
Friday
SESSION 90:
PROGRESS AND UPDATES ON MEDICAL TREATMENTS AND OTHER SUBJECTS
Moderators:Elliot L. Chaikof, MD, PhD / Andrew N. Nicolaides, MS, FRCS
|
|
| SESSION 90 SCHEDULE | |
| MEDICAL TREATMENTS | |
| 2:06 PM - 2:11 PM | How To Incorporate A Dedicated Cardiovascular Disease Prevention Program Into A Vascular Practice And Make It Work |
| Presenter(s):Sam S. Ahn, MD, FACS, MBA | |
| View Slides in PDF | |
| 2:12 PM - 2:17 PM | Value Of Cilostazol (Pletal) In Vascular Patients: It’s Not Just For Claudication: Beneficial Effects, Who Should Get And At What Dose |
| Presenter(s):Richard J. Powell, MD | |
| View Slides in PDF | |
| 2:18 PM - 2:23 PM | With Vascular Patients And Vascular Procedures, When Are Beta Blockers Helpful: In What Dose And With What Precautions |
| Presenter(s):Mark L. Friedell, MD | |
| View Slides in PDF | |
| 2:24 PM - 2:29 PM | Preoperative Beta Blockers Reduce Operative Mortality (30-Day) And Non-Cardiac Morbidity After Elective Open AAA Repair |
| Presenter(s):Mahmoud B. Malas, MD, MHS | |
| View Slides in PDF | |
| 2:30 PM - 2:35 PM | What Is New In Best Medical Therapy For Vascular Patients: How Can Its Effectiveness Be Measured: What LDL Level Should We Strive For; Can The LDL Level Ever Be Too Low |
| Presenter(s):Russell H. Samson, MD, RVT, FACS | |
| View Slides in PDF | |
| 2:36 PM - 2:41 PM | When And Why Should Vascular Surgeons Prescribe Maximal Dose Statins: What Dose Is This And What Are The Risks |
| Presenter(s):Anthony J. Comerota, MD, FACS, FACC | |
| View Slides in PDF | |
| 2:42 PM - 2:47 PM | High Dose Ruvostatin (Crestor) Leads To Decreased Renal Damage After Contrast Arteriography: Should It Be Used More Widely As A Renal Protective Agent |
| Presenter(s):Olivier H.J. Koning, MD, PhD | |
| View Slides in PDF | |
| 2:48 PM - 2:53 PM | When After Coronary Stenting With A DES Or BMS Is It Safe To Stop Clopidogrel And Perform An Open Operation: The Latest Update |
| Presenter(s):Don Poldermans, MD | |
| View Slides in PDF | |
| 2:54 PM - 3:02 PM | Panel Discussion |
| Moderator(s): Anthony J. Comerota, MD, FACS, FACC / Russell H. Samson, MD, RVT, FACS | |
| 3:02 PM - 3:07 PM | Mortality Is A More Important End Point Than Stroke In Patients With An Asymptomatic Carotid Stenosis: What Can Be Done About It |
| Presenter(s):Andrew N. Nicolaides, MS, FRCS | |
| View Slides in PDF | |
| 3:08 PM - 3:13 PM | Postoperative And Post-Procedural Myocardial Infarctions (MIs): Evaluation, Risk Factors And Optimal Prevention And Treatment: We Can Do More |
| Presenter(s):Peter Henke, MD | |
| View Slides in PDF | |
| CCSVI (SEE ALSO SESSION 97) | |
| 3:14 PM - 3:19 PM | Update On CCSVI And Interventions For MS: Role Of Autonomic Nervous System And Is There Still A Role For Angioplasty Of Vein Stenoses |
| Presenter(s):Donald B. Reid, MD | |
| 3:20 PM - 3:25 PM | How Are 3D Navigational Tools Helpful In Lower Extremity Interventions |
| Presenter(s):Jos C. van den Berg, MD, PhD | |
| View Slides in PDF | |
| 3:26 PM - 3:31 PM | When Is Duplex Ultrasound Surveillance A Safe Alternative For CT Or MR – After EVAR; After Lower Extremity Revascularizations: What Are The Requirements |
| Presenter(s):Keith D. Calligaro, MD / Matthew J. Dougherty, MD | |
| View Slides in PDF | |
| 3:32 PM - 3:39 PM | Panel Discussion |
| 3:40 PM - 4:00 PM | Break – Visit Exhibits And Pavilions (2nd and 3rd Floors) |
| END OF SESSION 90 | |
| previous | next |